Dissemin
Language
العربيّة
Deutsch
English
Español
Suomi
Français
한국어
Македонски
Português
Português Brasileiro
Русский
Svenska
Türkçe
简体中文
繁體中文
Login
Dissemin
Dorota Zarębska-Michaluk
Jacobson et al., 2014
Links
ORCID
Tools
Export citation
×
Format
BibTeX
@article{Jacobson2014, author = {Jacobson, I. and Zeuzem, S. and Flisiak, R. and Knysz, B. and Lueth, S. and Zarebska-Michaluk, D. and Janczewska, E. and Ferenci, P. and Diago, M. and Zignego, A. and Safadi, R. and Baruch, Y. and Abdurakhmanov, D. and Shafran, S. and Thabut, D. and Bruck, R. and Gadano, A. and Thompson, A. and Kopit, J. and McPhee, F. and Michener, T. and Hughes, E. and Yin, P. and Noviello, S.}, month = {jan}, title = {Daclatasvir vs telaprevir in combination with peginterferon alfa/ribavirin in treatment-naive patients with HCV genotype 1: phase 3 COMMAND-3 results}, year = {2014} }
Export citation
Search in Google Scholar
Daclatasvir vs telaprevir in combination with peginterferon alfa/ribavirin in treatment-naive patients with HCV genotype 1: phase 3 COMMAND-3 results
Journal article published in 2014 by
I. Jacobson
,
S. Zeuzem
,
R. Flisiak
,
B. Knysz
,
S. Lueth
,
D. Zarebska-Michaluk
,
E. Janczewska
,
P. Ferenci
,
M. Diago
,
A. Zignego
,
R. Safadi
,
Y. Baruch
,
D. Abdurakhmanov
,
S. Shafran
,
D. Thabut
and
other authors.
I. Jacobson
,
S. Zeuzem
,
R. Flisiak
,
B. Knysz
,
S. Lueth
,
D. Zarebska-Michaluk
,
E. Janczewska
,
P. Ferenci
,
M. Diago
,
A. Zignego
,
R. Safadi
,
Y. Baruch
,
D. Abdurakhmanov
,
S. Shafran
,
D. Thabut
,
R. Bruck
,
A. Gadano
,
A. Thompson
,
J. Kopit
,
F. McPhee
,
T. Michener
,
E. Hughes
,
P. Yin
,
S. Noviello
Show less
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text:
Unavailable
Preprint
: policy unknown
Upload
Postprint
: policy unknown
Upload
Published version
: policy unknown
Upload